1. Merck KGaA
2. Genscript Corporation
3. Lonza Group AG
4. bioMerieux SA
5. Novo Holdings A/S
6. Eurofins Scientific SE
7. Charles River Laboratories International Inc.
8. WuXi AppTec Co. Ltd.
Published | Pages | Publisher | Report code |
---|---|---|---|
Apr 2024 | 184 | TechSci Research | ASDR-663165 |
1. Merck KGaA
2. Genscript Corporation
3. Lonza Group AG
4. bioMerieux SA
5. Novo Holdings A/S
6. Eurofins Scientific SE
7. Charles River Laboratories International Inc.
8. WuXi AppTec Co. Ltd.